EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -0.0015
March 31, 2026 -0.0013
December 31, 2025 -0.0013
September 30, 2025 -0.0069
June 30, 2025 -0.1867
March 31, 2025 -0.362
December 31, 2024 0.6066
September 30, 2024 -14.83
March 31, 2024 -14.75
December 31, 2023 -14.67
September 30, 2023 -15.80
June 30, 2023 -15.50
March 31, 2023 -15.54
December 31, 2022 -16.26
September 30, 2022 -16.36
June 30, 2022 -1.724
March 31, 2022 -2.088
December 31, 2021 -2.115
September 30, 2021 -27.82
June 30, 2021 -27.43
March 31, 2021 -27.22
December 31, 2020 -26.48
September 30, 2020 -1.581
June 30, 2020 -1.824
Date Value
March 31, 2020 -1.581
December 31, 2019 -2.418
September 30, 2019 -1.449
June 30, 2019 -1.179
March 31, 2019 -5.616
June 30, 2018 -6.592
March 31, 2018 -506.01
March 31, 2016 -514.92
December 31, 2015 -508.76
September 30, 2015 -515.07
June 30, 2015 -23.72
March 31, 2015 -1544.72
December 31, 2014 -1551.33
September 30, 2014 -1553.13
June 30, 2014 -1572.08
March 31, 2014 -50.76
December 31, 2013 -90.81
September 30, 2013 -125.78
June 30, 2013 -143.68
September 30, 2010 -135.04
June 30, 2010 -90.04
March 31, 2010 -45.04
September 30, 2009 -0.045

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
SCWorx Corp. -39.65
Health Catalyst, Inc. -2.826
GoodRx Holdings, Inc. 0.047
Claritev Corp. -17.01
iSpecimen, Inc. -50.28